http://www.outlooktherapeutics.com
Outlook Therapeutics, Inc. Company Intro
NEWS JULY 17, 2020
Outlook Therapeutics Announces Closing of $1.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules More JULY 7, 2020
Outlook Therapeutics Completes Patient Enrollment for NORSE 2 Study of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) More
Industry
Healthcare
Outlook Therapeutics, Inc. Headquaters
7 Clarke Drive
Cranbury,08512
United States
Outlook Therapeutics, Inc. Share price
17 May 2023 13:41 GMT
$1.1900
0.0 (0.0 %)
Outlook Therapeutics, Inc. Market cap
$302.867 M
WMC RANKING
2023
Outlook Therapeutics, Inc. # 192
BiotechnologyLatest Outlook Therapeutics, Inc. News
03 Oct 2023
Viscosupplementation Market Status and Outlook: 2023 ...
List of Top Key Players in Viscosupplementation Market Report are: Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia...
03 Oct 2023
BioBlast w/e 02 Oct 23
29 SEP 2023 | US | Outlook Therapeutics FDA Meeting for Ophthalmic Formulation of Bevacizumab. Outlook Therapeutics announced that it requested a Type A...
03 Oct 2023
There is no doubt that Outlook Therapeutics Inc (OTLK) ticks ...
Outlook Therapeutics Inc (NASDAQ: OTLK) stock jumped 1.22% on Monday to $0.22 against a previous-day closing price of $0.22. With 1.9 million shares changed...
WMC Market Score
WMC Market to Revenue Score
Outlook Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Outlook Therapeutics, Inc. | USD | $0 | $48,605 | $-40,499 | $3,029M | 192 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Outlook Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Post vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Outlook Therapeutics, Inc. | 0.10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Incyte Corporation | 43.17 | 5.03 | 0.04 | 0 | 0 | 0 | 2.53 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
